Search results
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 21 hours agoThe company also reported net sales of $109m and an operating profit of $40m in 2023. Cycle ...
EMA CHMP endorses Mirum Pharmaceuticals’ LIVMARLI for PFIC
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 1 day agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 1 day agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 1 day agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...
Acid for the ear
Politico· 14 hours agoThe Pentagon is investigating how psychedelic medicine can help servicemembers — beyond mental health issues. The agency has awarded $825,000 to...
Changing Your Diet and Lifestyle May Slow Down Alzheimer's
Time via AOL· 1 day agoAdministration is expected to make a decision about another such promising therapy. But in addition...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 18 hours agoThe application was based on data from the FLAURA2 phase III study. Tagrisso was approved for...
Bayer and PAPACKS to redefine consumer health packaging
Packaging Gateway via Yahoo Finance· 22 hours agoPharmaceutical and biotechnology company Bayer has collaborated with packaging provider PAPACKS on...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030 | The Motley Fool
The Motley Fool· 6 days agoEli Lilly and Novo Nordisk are rivals in the drug market for diabetes treatment, a competition that...